← Eichor
Study identifier: NCT06057051 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

Condition: Glaucoma  ·  Sponsor: Glaukos Corporation

PhaseNA
Planned participants245
Who can joinAll sexes, 35 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment

This description comes directly from the study's public registry record.

Talk to the study team

Dari Parizadeh  ·  949-481-0575  ·  dparizadeh@glaukos.com

Kerry Stephens  ·  949-481-8057  ·  kstephens@glaukos.com

Always discuss trial participation with your own doctor first.

Locations (1)

Glaukos Investigator SiteCincinnati, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06057051